These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 15107166)

  • 1. Social context and the experience of a sample of U.S. women taking RU-486 (mifepristone) for early abortion.
    Fielding SL; Schaff EA
    Qual Health Res; 2004 May; 14(5):612-27. PubMed ID: 15107166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Knowledge and perceptions of medical abortion among potential users.
    Harvey SM; Beckman LJ; Castle MA; Coeytaux F
    Fam Plann Perspect; 1995; 27(5):203-7. PubMed ID: 9104607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Having an abortion using mifepristone and home misoprostol: a qualitative analysis of women's experiences.
    Fielding SL; Edmunds E; Schaff EA
    Perspect Sex Reprod Health; 2002; 34(1):34-40. PubMed ID: 11990637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relationship of contextual factors to women's perceptions of medical abortion.
    Harvey SM; Beckman LJ; Roberts Branch M
    Health Care Women Int; 2002; 23(6-7):654-65. PubMed ID: 12418986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mifepristone followed in 24 hours to 48 hours by misoprostol for late first-trimester abortion.
    Bracken H; Ngoc NT; Schaff E; Coyaji K; Ambardekar S; Westheimer E; Winikoff B
    Obstet Gynecol; 2007 Apr; 109(4):895-901. PubMed ID: 17400851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The efficacy and acceptability of mifepristone medical abortion with home administration misoprostol provided by private providers linked with the hospital: a prospective study of 433 patients].
    Faucher P; Baunot N; Madelenat P
    Gynecol Obstet Fertil; 2005 Apr; 33(4):220-7. PubMed ID: 15894206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A pilot study of mifepristone and misoprostol administered at the same time for abortion up to 49 days gestation.
    Murthy AS; Creinin MD; Harwood B; Schreiber C
    Contraception; 2005 May; 71(5):333-6. PubMed ID: 15854632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. WHO multinational study of three misoprostol regimens after mifepristone for early medical abortion.
    Honkanen H; Piaggio G; Hertzen H; Bártfai G; Erdenetungalag R; Gemzell-Danielsson K; Gopalan S; Horga M; Jerve F; Mittal S; Thi Nhu Ngoc N; Peregoudov A; Prasad RN; Pretnar-Darovec A; Shah RS; Song S; Tang OS; Wu SC;
    BJOG; 2004 Jul; 111(7):715-25. PubMed ID: 15198763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Medical termination of pregnancy with mifepristone--initial experience at the Sheba Medical Center].
    Machtinger R; Goldenberg M; Soriano D; Zolti M; Atlas M; Seidman DS
    Harefuah; 2003 Oct; 142(10):666-8, 719. PubMed ID: 14565062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mifepristone-induced early abortion and outcome of subsequent wanted pregnancy.
    Chen A; Yuan W; Meirik O; Wang X; Wu SZ; Zhou L; Luo L; Gao E; Cheng Y
    Am J Epidemiol; 2004 Jul; 160(2):110-7. PubMed ID: 15234931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mifepristone plus vaginal misoprostol vs vaginal misoprostol alone for medical abortion in gestation 63 days or less in Nepalese women: a quasi-randomized controlled trial.
    Chawdhary R; Rana A; Pradhan N
    J Obstet Gynaecol Res; 2009 Feb; 35(1):78-85. PubMed ID: 19215552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can mifepristone medication abortion be successfully integrated into medical practices that do not offer surgical abortion?
    Leeman L; Asaria S; Espey E; Ogburn J; Gopman S; Barnett S
    Contraception; 2007 Aug; 76(2):96-100. PubMed ID: 17656177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ability of the clinician and patient to predict the outcome of mifepristone and misoprostol medical abortion.
    Rossi B; Creinin MD; Meyn LA
    Contraception; 2004 Oct; 70(4):313-7. PubMed ID: 15451336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized trial of mifepristone and buccal or vaginal misoprostol for abortion through 56 days of last menstrual period.
    Middleton T; Schaff E; Fielding SL; Scahill M; Shannon C; Westheimer E; Wilkinson T; Winikoff B
    Contraception; 2005 Nov; 72(5):328-32. PubMed ID: 16246656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomised controlled trial comparing the efficacy of same-day administration of mifepristone and misoprostol for termination of pregnancy with the standard 36 to 48 hour protocol.
    Guest J; Chien PF; Thomson MA; Kosseim ML
    BJOG; 2007 Feb; 114(2):207-15. PubMed ID: 17305893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous very low dose mifepristone and vaginal misoprostol for medical abortion.
    Kapp N; Borgatta L; Ellis SC; Stubblefield P
    Contraception; 2006 May; 73(5):525-7. PubMed ID: 16627039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two mifepristone doses and two intervals of misoprostol administration for termination of early pregnancy: a randomised factorial controlled equivalence trial.
    von Hertzen H; Piaggio G; Wojdyla D; Marions L; My Huong NT; Tang OS; Fang AH; Wu SC; Kalmar L; Mittal S; Erdenetungalag R; Horga M; Pretnar-Darovec A; Kapamadzija A; Dickson K; Anh ND; Tai NV; Tuyet HT; Peregoudov A;
    BJOG; 2009 Feb; 116(3):381-9. PubMed ID: 19187370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increasing women's choices in medical abortion: a study of misoprostol 400 microg swallowed immediately or held sublingually following 200 mg mifepristone.
    Akin A; Dabash R; Dilbaz B; Aktün H; Dursun P; Kiran S; Aksan G; Doğan B; Winikoff B
    Eur J Contracept Reprod Health Care; 2009 Jun; 14(3):169-75. PubMed ID: 19565414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RU-486: the experience of users.
    Girault-laurence J
    Plan Parent Eur; 1991 Sep; 20(2):21. PubMed ID: 12284549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An illusion of power: qualitative perspectives on abortion decision-making among teenage women in Sweden.
    Ekstrand M; Tydén T; Darj E; Larsson M
    Perspect Sex Reprod Health; 2009 Sep; 41(3):173-80. PubMed ID: 19740236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.